Varex Imaging (VREX) director receives 8,483 shares as Deferred Stock Units settle

Rhea-AI Filing Summary

Varex Imaging Corp director Christine A. Tsingos reported the delivery of vested equity awards. On February 9, 2026, 8,483 Deferred Stock Units converted into an equal number of shares of Varex Imaging common stock at an exercise price of $0 per share.

These Deferred Stock Units were originally granted on February 9, 2023, vested on February 8, 2024, and were delivered in stock on the third anniversary of the grant date. After this transaction, Tsingos directly beneficially owns 42,655 shares of Varex Imaging common stock.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

TSINGOS CHRISTINE A

(Last) (First) (Middle)

C/O VAREX IMAGING CORP

1678 S. PIONEER ROAD

(Street)

SALT LAKE CITY UT 84104

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Varex Imaging Corp [ VREX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/09/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/09/2026		M		8,483	A	(1)	42,655	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Stock Units	(1)	02/09/2026		M			8,483	(2)	(2)	Common Stock	8,483	$0	0	D

Explanation of Responses:

1. Each Deferred Stock Unit converts into common stock on a one-for-one basis.

2. These Deferred Stock Units were issued on February 9, 2023, vested on February 8, 2024, and delivery of the vested Deferred Stock Units, in the form of common stock occurred on February 9, 2026, the third anniversary of the date of grant.

Remarks:

	/s/ Matthew A. Martinez, attorney-in-fact for Christine A. Tsignos	02/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Varex Imaging (VREX) report for Christine A. Tsingos?

Varex Imaging director Christine A. Tsingos reported the conversion of 8,483 Deferred Stock Units into an equal number of common shares on February 9, 2026. This was a stock delivery from previously granted equity, not an open-market purchase.

How many Varex Imaging (VREX) shares does Christine A. Tsingos own after this Form 4?

After the reported transaction, Christine A. Tsingos directly beneficially owns 42,655 shares of Varex Imaging common stock. This reflects the delivery of 8,483 shares from vested Deferred Stock Units and the resulting updated ownership total.

What are Deferred Stock Units in the Varex Imaging (VREX) Form 4 filing?

Deferred Stock Units are equity awards that convert into common shares on a future date. In this filing, each unit converted into one share of common stock, delivering 8,483 shares to director Christine A. Tsingos when they became payable in stock.

When were the Varex Imaging (VREX) Deferred Stock Units granted and delivered?

The Deferred Stock Units were granted on February 9, 2023, vested on February 8, 2024, and were delivered in the form of common stock on February 9, 2026. Delivery occurred on the third anniversary of the original grant date.

Did Christine A. Tsingos pay anything for the Varex Imaging (VREX) shares received?

The Form 4 shows an exercise price of $0 per share for the conversion of 8,483 Deferred Stock Units into common stock. This indicates the shares were delivered as part of compensation, rather than bought in a cash transaction on the open market.

Is the Varex Imaging (VREX) Form 4 transaction a purchase, sale, or equity award settlement?

The reported activity is an equity award settlement. 8,483 Deferred Stock Units converted into common stock upon delivery, coded as transaction type M, which typically reflects the exercise or conversion of a derivative security into underlying shares.